FDA Inspection
Piedmont Reproductive Endocrinology Group, PaPiedmont Reproductive Endocrinology Group, Pa – FDA Inspection, Jan 21, 2026
Record Details
This FDA Inspection record concerns Piedmont Reproductive Endocrinology Group, Pa, with an inspection on January 21, 2026, issued by the Atlanta District Office, covering biologics.
- Inspection Date
- January 21, 2026
- Product Type
- Biologics
View Company Profile
ID · 20389128-90c1-49f2-a420-f61b3f0997e6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1300792
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(e)Abbreviated procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Piedmont Reproductive Endocrinology Group, Pa
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 28, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 31, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 19, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 29, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Piedmont Reproductive Endocrinology Group, Pa
- FDA Inspection 1193365 - 2022-12-06
- FDA Inspection 1122803 - 2020-01-28
- FDA Inspection 1040306 - 2018-01-31
- FDA Inspection 966721 - 2016-04-19
- FDA Inspection 876598 - 2014-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.